Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Peroral Vorinostat (SAHA) in Patients With Refractory Histone Deacetylase-positive Uterine Sarcoma

NCT03509207 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT03509207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Peroral Vorinostat (SAHA) in Patients With Refractory Histone Deacetylase-positive Uterine Sarcoma
Lead sponsor
Medical University of Graz
Phase
Phase 2
Overall status
Terminated
Start date
December 14, 2017
Completion date
February 4, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinosarcomas uterine, endometrial stromal tumors, leiomyosarcoma